NDC 50090-7110-01 - Bupropion Hydrochloride (XL)
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7110
- Requested NDC
- 50090-7110-01
- Package NDCs from labels
- 50090-7110-0, 50090-7110-1, 50090-7110-2, 50090-7110-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-03-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bupropion Hydrochloride (XL) - A-S Medication Solutions | A-S Medication Solutions | 2024-03-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7110-0 | Bupropion Hydrochloride(XL) | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 1 | |
| 50090-7110-1 | Bupropion Hydrochloride(XL) | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 1 | |
| 50090-7110-2 | Bupropion Hydrochloride(XL) | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7110 | BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 3 package rows | 20240315_8ae81b03-b447-4a3f-8ed9-ebf75ee52b49.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7110-0 | EA - Each | 50090-7110 | 51505f8f-bfda-488f-84a9-fb0179f9c05c | 1 | 2024-04-05 |
| 50090-7110-1 | EA - Each | 50090-7110 | eaa34686-05e2-4ecd-a549-fb1f4c146844 | 1 | 2024-04-05 |
| 50090-7110-2 | EA - Each | 50090-7110 | 59572bec-96e6-4013-a6b3-c7ad67f46bbb | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | Aurobindo Pharma Limited | cc344f7c-0eb3-4e63-a09e-b682acca2bb5 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 993541 ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | c60855ca-4fa0-4004-ad19-4abb61100c43 | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | 993541 ZG7E5POY8O |
| GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS | POLYVINYL ALCOHOL, POVIDONE | AmerisourceBergen | ce6852a8-c5e6-403d-a7b4-a2e85d1ebb1f | 2026-07-22 | Warnings | FZ989GH94E |
| Bupropion Hydrochloride XL | BUPROPION HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | eb946d81-b4f4-42e9-aa7a-31d76d15629c | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 993541 ZG7E5POY8O |
| FUNGAL NAIL TREATMENT kit .cream. | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56c9d9fa-09ad-e26a-e063-6394a90a0ed9 | 2026-07-17 | Warnings | 6DC9Q167V3 |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Global Equipment Company | bc93a1e8-aa3c-6735-e053-2995a90ad6e8 | 2026-07-16 | Warnings | 6DC9Q167V3 |
| Revitalize Energizing Eye Drops | NAPHAZOLINE HYDROCHLORIDE ,PROPYLENE GLYCOL | Revitalize Energy Inc. | 518aac87-1642-4b2f-bca1-b74d21261eea | 2026-07-16 | Warnings | 6DC9Q167V3 |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 740534d3-59b5-4938-8e38-16275a14438c | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 993541 ZG7E5POY8O |
| Prid | ICHTHAMMOL, CALCIUM SULFIDE, CALENDULA OFFICINALIS FLOWERING TOP, ARNICA MONTANA, ECHINACEA ANGUSTIFOLIA, SILICON DIOXIDE, SULFUR | Hyland's Inc. | 49689eeb-7790-07f1-e063-6294a90a2df2 | 2026-07-16 | Warnings | ETJ7Z6XBU4 |
| Leg Cramps PM | OYSTER SHELL CALCIUM CARBONATE, CRUDE, CAUSTICUM, MATRICARIA RECUTITA, CINCHONA OFFICINALIS BARK, COPPER, LYCOPODIUM CLAVATUM SPORE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF, SILICON DIOXIDE, AND SULFUR | Hyland's Inc. | b0574a7e-88fa-417e-b6d5-60ced59eba47 | 2026-07-15 | Warnings | ETJ7Z6XBU4 |
| Bupropion Hydrochloride XL | BUPROPION HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 1af14d2e-c64d-44b7-a402-8869e8e30661 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 993541 ZG7E5POY8O |
| Bupropion Hydrochloride XL | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 9aa3753f-1a0e-4faa-995f-67e29b320737 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride XL | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | b2e6c30f-a33c-4854-ab19-bc9f65880374 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Jacksons Cell Salts SILICA 12X 12 | SILICEA | Zettl Health Inc. | 5647dafc-1fff-6a25-e063-6294a90a8b4f | 2026-07-10 | ETJ7Z6XBU4 | |
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | a613cfd3-1aa1-49c5-b742-b105c97d73f1 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 993541 ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Coupler LLC | 5604eb14-bab4-4f06-e063-6294a90a6920 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 867d3876-6974-4e89-bc45-9e60e84b401c | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 4fbe64aa-f8f4-45fa-88ae-e844997703ae | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | ETJ7Z6XBU4 |
| Bambusa Stannum | BAMBUSA STANNUM | Uriel Pharmacy Inc. | a0d4d0ac-e2d2-4381-8f93-e41719521859 | 2026-06-30 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.